Drug-labels.com

B06AC Drugs used in hereditary angioedema

ATC class of level 4 – chemical subgroup

This page lists the patient medication information or the product monograph for 13 drugs in this drug class and its subclasses.

Place in the ATC system

  1. B Blood and blood forming organ drugs 393 drugs
    1. B06 Other hematological agents 15 drugs
      1. B06A Other hematological agents 15 drugs
        1. B06AC Drugs used in hereditary angioedema 13 drugs
          1. B06AC01 C1-inhibitor, plasma derived 3 drugs
          2. B06AC02 Icatibant 6 drugs
          3. B06AC05 Lanadelumab 1 drug
          4. B06AC06 Berotralstat 1 drug
          5. B06AC07 Garadacimab 1 drug
          6. B06AC09 Donidalorsen 1 drug

Active ingredients of the class

Drugs in the class and its subclasses

DrugRx or OTC
Andembry PM (B06AC07 Garadacimab) prescription (Rx)
Berinert 500 PM (B06AC01 C1-inhibitor, plasma derived) –
Cinryze PM (B06AC01 C1-inhibitor, plasma derived) –
Dawnzera PM (B06AC09 Donidalorsen) prescription (Rx)
Firazyr PM (B06AC02 Icatibant) prescription (Rx)
Haegarda (B06AC01 C1-inhibitor, plasma derived) –
Icatibant Injection (Accord Healthcare) (B06AC02 Icatibant) prescription (Rx)
Icatibant Injection (Jamp Pharma) PM (B06AC02 Icatibant) prescription (Rx)
Icatibant Injection (Juno Pharmaceuticals) PM (B06AC02 Icatibant) prescription (Rx)
Mint-Icatibant PM (B06AC02 Icatibant) prescription (Rx)
Orladeyo (B06AC06 Berotralstat) prescription (Rx)
Takhzyro PM (B06AC05 Lanadelumab) prescription (Rx)
Teva-Icatibant PM (B06AC02 Icatibant) prescription (Rx)

Other classes of the same level

Other names of the drug class

Sources

  • Patient medication information and product monographs: Health Canada, Drug Product Database
  • Active ingredients, ATC codes and Rx or OTC status: Health Canada, Drug Product Database
  • World Health Organization (WHO): ATC/DDD system, class B06AC

Ask your doctor or pharmacist for advice.